Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.

Annals of surgical oncology - 1 Feb 2009

Lee Xiaolong, Gao Ming, Ji Yifeng, Yu Yang, Feng Ying, Li Yigong, Zhang Yan, Cheng Wenyuan, Zhao Wenchuan

Abstract excerpt

Papillary thyroid cancers often occur as microcarcinoma. Some papillary thyroid microcarcinoma (PTMC) have been considered to be high aggressive according to advanced disease stages, extrathyroidal extension, and severe cervical lymph node metastasis. Although several factors are thought to predict the occurrence of aggressiveness from PTMCs, the origin of aggressiveness has been rarely studied. To answer this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinoma, Papillary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to Lymphatic Metastasis

Share to Polymorphism, Restriction Fragment Length

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 19034577
DOI: 10.1245/s10434-008-0233-3

Genes

BRAF

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma.PMID 19034577Read ↗

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.Semantic proximity Read ↗

Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.Semantic proximity Read ↗

BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.Semantic proximity Read ↗

Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.Semantic proximity Read ↗

[Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].Semantic proximity Read ↗

BRAFV600E mutation does not predict lymph node metastases and recurrence in Chinese papillary thyroid microcarcinoma patients.Semantic proximity Read ↗

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.Semantic proximity Read ↗

[Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].Semantic proximity Read ↗

BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation.Semantic proximity Read ↗

BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.Semantic proximity Read ↗

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma.Semantic proximity Read ↗

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.